Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of the phase I part of this study is to determine the recommended Phase 2 dose of pemetrexed, cisplatin, and involved-field radiotherapy in the treatment of patients with LS-SCLC. The primary objective of the phase II part of this study is to further delineate the activity of this regimen at the recommended dose in terms of overall response rate
Critère d'inclusion
- Limited Stage Small Cell Lung Cancer